Pharma Marketing Blog: FDA's Reprint Distribution Guidelines are "Counterintuitive" & "Indecent"

Pharma Marketing Blog

A "Must Read" Blog for Insiders. --Wall Street Journal "...often-entertaining, always informative..." --MedAdNews

Monday, March 23, 2015

FDA's Reprint Distribution Guidelines are "Counterintuitive" & "Indecent"

FDA's Reprint Distribution Guidelines are "Counterintuitive" & "Indecent"

PharmaGuy at 1:31 PM

No comments:

Post a Comment

View web version

About the Author

Unknown
Vlad

Powered by Blogger.